# Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances

Page: https://stenobird.com/podcast/hematologic-oncology-update-916423/acute-myeloid-leukemia-year-in-review-series-on-relevant-new-datasets-and-advances
Text version: https://stenobird.com/podcast/hematologic-oncology-update-916423/acute-myeloid-leukemia-year-in-review-series-on-relevant-new-datasets-and-advances.md
Podcast: [Hematologic Oncology Update](https://stenobird.com/podcast/hematologic-oncology-update-916423)
Published: 2026-04-20T13:00:00+00:00
Episode link: https://hematologic-oncology.captivate.fm/episode/5991-yir2025-meninaml
Audio file: https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/e56b924d-a34f-45a0-afa6-9e9cdd81a0ce.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/hematologic-oncology-update-916423/episodes/acute-myeloid-leukemia-year-in-review-series-on-relevant-new-datasets-and-advances
Duration seconds: 3534

## Resource

Dr Amir Fathi from Massachusetts General Hospital in Boston, Massachusetts, and Dr Eunice S Wang from Roswell Park Comprehensive Cancer Center in Buffalo, New York, discuss key clinical trial data surrounding the use of menin inhibitors in the management of AML. CME information and select publications here .

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/hematologic-oncology-update-916423/episodes/acute-myeloid-leukemia-year-in-review-series-on-relevant-new-datasets-and-advances/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/hematologic-oncology-update-916423/acute-myeloid-leukemia-year-in-review-series-on-relevant-new-datasets-and-advances.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.